Jagsonpal Pharmaceuticals has announced the sale of its non-operational Faridabad facility to Regalia Laminates LLP for Rs 41 crore. The sale is expected to be completed by October 31, 2024.
New Delhi, Jul 25 (PTI) Jagsonpal Pharmaceuticals Ltd on Thursday said it will sell its Faridabad facility to Regalia Laminates LLP for a consideration of Rs 41 crore.
The company had in November last year announced plans to divest the Faridabad unit.
"We now wish to inform you that the company has entered into an agreement to divest the said facility," Jagsonpal Pharmaceuticals said in a regulatory filing.
It is being sold to Regalia Laminates LLP and the sale is expected to be completed on or before October 31, 2024, the company said.
The consideration proposed to be received from the sale is Rs 41 crore, the filing said.
The facility was not operational and did not contribute any revenue in the last year, it added.
Home » Market News » Jagsonpal Pharmaceuticals Sells Faridabad Facility for Rs 41 Cr
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback